Contract
Freelance Copy Supervisor
Pharma agency
Posted on 10/7/2025
Avalere Health
201-500 employees
Healthcare consulting with advisory, policy, marketing
No salary listed
Company Does Not Provide H1B Sponsorship
Remote in USA
Remote
 Content & Writing (1) |
|---|
- 5-7 years of professional writing experience, with at least 2 years of pharmaceutical advertising copywriting experience
- At least 2 years of supervisory experience
- Demonstrated track record for independently producing successful, compelling, and strategically sound pharmaceutical promotional materials in 2 or more therapeutic categories
- Comfortable working within tight deadlines
- Advanced PC or Mac experience with all Adobe Creative Suite and MS Office Suite
- Write effective promotional copy, acting as a primary copywriter on at least one product
- Review material produced by direct reports, as applicable, including review of final manuscripts, as applicable
- Supervise senior copywriter(s), copywriter(s) and junior copywriter(s), as applicable
- Demonstrate thorough knowledge of assigned therapeutic categories
- Participate in strategic promotional planning for assigned products
- Understand and ensure compliance with the editorial process
- Demonstrate mastery of manuscript submission process, including referencing and regulatory details of assigned product(s)
- Interact with Art Directors to develop creative concepts and executions for assigned products
- Present concepts and promotional material to the client
- Assist in product launches
Avalere Health is a healthcare consulting firm that provides advisory, medical affairs, and marketing services to providers, payers, and life sciences companies. Its offerings help clients navigate the healthcare market through a proprietary SenseMaking model that combines data analysis, policy expertise, and market insights. This approach supports areas such as market access and reimbursement strategies, policy analysis, and government affairs, with revenue generated from consulting fees. The company differentiates itself by applying its SenseMaking framework to deliver targeted, data-backed recommendations across the healthcare ecosystem, integrating policy, market, and clinical considerations for each client. Its goal is to help clients make informed decisions, optimize performance, and achieve their business objectives in a complex and evolving healthcare environment.
Company Size
201-500
Company Stage
Acquired
Total Funding
$140M
Headquarters
null
Founded
2000
Simplify's Take
What believers are saying
- Japan office leverages oncology, diabetes, immunology markets for rapid revenue growth.
- Inovalon acquisition enhances SenseMaking with advanced health data analytics.
- New hires like Emily Donaldson and Corrina Safeio bolster policy and marketing expertise.
What critics are saying
- Amar Urhekar's unproven three-pillar strategy fails within 12-24 months against boutiques.
- C-suite marketing reshuffles with Sarah Hall disrupt client continuity in 6-12 months.
- Trump 2025 policies collapse US drug pricing advisory revenue in 6-18 months.
What makes Avalere Health unique
- Proprietary SenseMaking model intersects science, society, and systems for unified strategies.
- Integrated advisory, medical, and marketing services span full product lifecycle.
- Global expansion includes Japan office led by Junji Yokokawa targeting oncology growth.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Wellness Program
Paid Vacation
Flexible Work Hours
Hybrid Work Options
Company News
Avalere, part of Avalere Health, convenes eleven strategistsWASHINGTON, Jan. 15, 2025 /PRNewswire/ -- Eleven leading policy strategists are scheduled to debate how market changes and the Trump administration will shape 2025, impacting drug pricing, health plan design and patient access to needed therapies. The annual live webinar, "2025 Healthcare Industry Outlook: Opportunity Through Uncertainty" is scheduled for Thursday, January 23 at 11:00 a.m. ET
Urhekar joined Avalere Health in 2023 as Chief Operations Officer (COO) to unify the organization and build a global interdisciplinary offering across the product lifecycle.
Avalere Health promoted COO Amar Urhekar to the CEO post on Thursday morning.
Shawn Murphy, VP, Thought Leadership Innovation Foundation (TLI)Limb loss and limb difference impact millions of people globally, with over 2.3 million individuals in the United States alone who are affected, a number expected to rise to 3.6 million by 2050. This rise in prevalence presents significant healthcare and economic challenges, necessitating innovative, data-driven solutions to improve patient care, quality of life (QOL) and healthcare equity. The National Institutes of Health (NIH) has taken a leading role in addressing these challenges by supporting the creation of a national registry to capture comprehensive data on limb loss and limb difference. This registry collects crucial patient information that helps inform both clinical care and research. Building on this, the not-for-profit community is now advancing these efforts forward, ensuring that data collection becomes a cornerstone of future advancements in this field of healthcare.Historically, limb loss and limb difference care have been constrained by fragmented and siloed data and outdated research. However, advances in data analytics are contemporizing the field by offering insights into patient outcomes and informing more effective healthcare policies. A registry allows for the consolidation of this data into valuable information, providing a holistic view of patient demographics, clinical outcomes and the effectiveness of treatments over time. Limb loss and limb difference place a substantial financial burden on individuals and healthcare systems, with lifetime healthcare costs averaging $509,275 for someone with limb loss, compared to $361,200 for those without
With over two decades of healthcare marketing experience, Muredda joins Ogilvy from Avalere Health, where he served as President of Marketing.